Adriaansen, J.J., Post, M.W., de Groot, S., van Asbeck, F.W., Stolwijk-Swuste, J.M., Tepper, M. and Lindeman, E. 2013. Secondary health conditions in persons with spinal cord injury: a longitudinal study from one to five years post-discharge. Journal of rehabilitation medicine. 45, 1016-1022.
Amini, H., Heshmati, M. and Jalali, M. 2020. The Study of the Effect of Deprenyl on Gliosis after Spinal Cord Compression in Adult Rat. Daneshvar Medicine. 16, 27-36.
Baliño, P., Gómez-Cadenas, A., López-Malo, D., Romero, F.J. and Muriach, M. 2019. Is there a role for abscisic acid, a proven anti-inflammatory agent, in the treatment of ischemic retinopathies?. Antioxidants. 8, 104.
Bracken, M.B. and Holford, T.R. 1993. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS. Journal of neurosurgery. 79, 500-50.
Bruzzone, S., Moreschi, I., Usai, C., Guida, L., Damonte, G., Salis, A., Scarfi, S., Millo, E., De Flora, A. and Zocchi, E. 2007. Abscisic acid is an endogenous cytokine in human granulocytes with cyclic ADP-ribose as second messenger. Proceedings of the National Academy of Sciences. 104, 5759-5764.
David, S., López-Vales, R. and Yong, V.W. 2012. Harmful and beneficial effects of inflammation after spinal cord injury: potential therapeutic implications. Handbook of clinical neurology. 109, 485-502.
Dimitrijevic, M.R., Danner, S.M. and Mayr, W. 2015. Neurocontrol of movement in humans with spinal cord injury. Artificial organs. 39, 823-833.
Fehlings, M.G., Wilson, J.R., Harrop, J.S., Kwon, B.K., Tetreault, L.A., Arnold, P.M., Singh, J.M., Hawryluk, G. and Dettori, J.R. 2017. Efficacy and safety of methylprednisolone sodium succinate in acute spinal cord injury: a systematic review. Global spine journal. 7, 116S-137S.
Freyermuth-Trujillo, X., Segura-Uribe, J.J., Salgado-Ceballos, H., Orozco-Barrios, C.E. and Coyoy-Salgado, A. 2022. Inflammation: a target for treatment in spinal cord injury. Cells. 11, 2692.
Göritz, C., Dias, D.O., Tomilin, N., Barbacid, M., Shupliakov, O. and Frisén, J. 2011. A pericyte origin of spinal cord scar tissue. Science. 333, 238-242.
Guri, A.J., Misyak, S.A., Hontecillas, R., Hasty, A., Liu, D., Si, H. and Bassaganya-Riera, J. 2010. Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall. The Journal of nutritional biochemistry. 21, 1178-1185.
Guri, A.J., Hontecillas, R., Ferrer, G., Casagran, O., Wankhade, U., Noble, A.M., Eizirik, D.L., Ortis, F., Cnop, M., Liu, D. and Si, H. 2008. Loss of PPARγ in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue. The Journal of nutritional biochemistry. 19, 216-228.
Hoag, T., Baolian, L., Zhideng, L., Jinyan, Z., Jie, Y. and Juan, Z. 2006. New use of natural abscisic acid in developing" differentation inducer". drugs of tumor cells. 18, 578-589.
Jha, R.M., Kochanek, P.M. and Simard, J.M. 2019. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology. 145, 230-246.
Kwon, B.K., Fisher, C.G., Dvorak, M.F. and Tetzlaff, W. 2005. Strategies to promote neural repair and regeneration after spinal cord injury. Spine. 30, S3-S13.
Li, H.H., Hao, R.L., Wu, S.S., Guo, P.C., Chen, C.J., Pan, L.P. and Ni, H. 2011. Occurrence, function and potential medicinal applications of the phytohormone abscisic acid in animals and humans. Biochemical pharmacology. 82, 701-712.
Lievens, L., Pollier, J., Goossens, A., Beyaert, R. and Staal, J. 2017. Abscisic acid as pathogen effector and immune regulator. Frontiers in plant science. 8, 587.
Livingston, V.W., Livingston Virginia WC. 1976. Abscisic acid tablets and process. U.S. Patent 3,958,025.
Lytle, J.M. and Wrathall, J.R. 2007. Glial cell loss, proliferation and replacement in the contused murine spinal cord. European Journal of Neuroscience. 25, 1711-1724.
Magnone, M., Sturla, L., Jacchetti, E., Scarfì, S., Bruzzone, S., Usai, C., Guida, L., Salis, A., Damonte, G., De Flora, A. and Zocchi, E. 2012. Autocrine abscisic acid plays a key role in quartz‐induced macrophage activation. The FASEB Journal. 26, 1261-1271.
Mollashahi, M., Abbasnejad, M. and Esmaeili-Mahani, S., 2018. Phytohormone abscisic acid elicits antinociceptive effects in rats through the activation of opioid and peroxisome proliferator-activated receptors β/δ. European Journal of Pharmacology, 832, 75-80.
Morin-Richaud, C., Feldblum, S. and Privat, A. 1998. Astrocytes and oligodendrocytes reactions after a total section of the rat spinal cord. Brain research. 783, 85-101.
Myers, R.R., Campana, W.M. and Shubayev, V.I. 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug discovery today. 11, 8-20.
Popovich, P.G. and Longbrake, E.E. 2008. Can the immune system be harnessed to repair the CNS?. Nature Reviews Neuroscience. 9, 481-493.
Rezaeezadeh Roukerd, M., Motaghi, S., Sadeghi, B. and Abbasnejad, M. 2022. Protective effect of abscisic Acid in a spinal cord injury model mediated by suppressed neuroinflammation. Iranian Journal of Veterinary Science and Technology. 14, 42-51.
Sehitoglu, M.H., Guven, M., Yüksel, Y., Akman, T.A.R.I.K., Aras, A.B., Farooqi, A.A. and Cosar, M., 2016. The effect of glycyrrhizic acid on traumatic spinal cord injury in rats. Cellular and Molecular Biology, 62, 2-8.
Sultan, I., Lamba, N., Liew, A., Doung, P., Tewarie, I., Amamoo, J.J., Gannu, L., Chawla, S., Doucette, J., Cerecedo-Lopez, C.D. and Papatheodorou, S. 2020. The safety and efficacy of steroid treatment for acute spinal cord injury: a systematic review and meta-analysis. Heliyon. 6, 03414.
Taoka, Y. and Okajima, K. 1998. Spinal cord injury in the rat. Progress in neurobiology. 5, 341-358.
Turtle, J.D., Henwood, M.K., Strain, M.M., Huang, Y.J., Miranda, R.C. and Grau, J.W. 2019. Engaging pain fibers after a spinal cord injury fosters hemorrhage and expands the area of secondary injury. Experimental neurology. 311, 115-124.
Vanzulli, I. and Butt, A.M. 2015. mGluR5 protect astrocytes from ischemic damage in postnatal CNS white matter. Cell Calcium. 58, 423-430.
Xiao, Y., Shan, K.R. and Guan, Z.Z. 2006. Effect of beta-amyloid peptides on alpha-7 nicotinic receptor status in astrocytes and neurons, and its relationship to pathogenesis of Alzheimer's disease. Zhonghua Bing li xue za zhi= Chinese Journal of Pathology. 35, 462-466.
Zelenka, M., Schäfers, M. and Sommer, C. 2005. Intraneural injection of interleukin-1β and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain, 116,257-263.
Zocchi, E., Hontecillas, R., Leber, A., Einerhand, A., Carbo, A., Bruzzone, S., Tubau-Juni, N., Philipson, N., Zoccoli-Rodriguez, V., Sturla, L. and Bassaganya-Riera, J. 2017. Abscisic acid: a novel nutraceutical for glycemic control. Frontiers in nutrition. 4, 24.